Case Report
Published on 18 Jan 2024
Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab
in Pediatric Critical Care
![Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab](https://www.frontiersin.org/files/myhome article library/1340360/1340360_Thumb_400.jpg)
- 1,393 views
Case Report
Published on 18 Jan 2024
in Pediatric Critical Care
Review
Published on 18 Jan 2024
in Pediatric Infectious Diseases
Original Research
Published on 18 Jan 2024
in Pediatric Orthopedics
Case Report
Published on 18 Jan 2024
in Genetics of Common and Rare Diseases
Original Research
Published on 18 Jan 2024
in Pediatric Surgery
Systematic Review
Published on 17 Jan 2024
in Genetics of Common and Rare Diseases
Case Report
Published on 16 Jan 2024
in Pediatric Nephrology
Original Research
Published on 16 Jan 2024
in Pediatric Cardiology
Review
Published on 16 Jan 2024
in Neonatology
Original Research
Published on 16 Jan 2024
in Pediatric Critical Care
Case Report
Published on 16 Jan 2024
in Pediatric Immunology
Review
Published on 16 Jan 2024
in Pediatric Gastroenterology, Hepatology and Nutrition
Original Research
Published on 16 Jan 2024
in Pediatric Orthopedics
Original Research
Published on 16 Jan 2024
in Pediatric Critical Care
Original Research
Published on 16 Jan 2024
in Pediatric Hematology and Hematological Malignancies
Original Research
Published on 16 Jan 2024
in Pediatric Nephrology